DNA GTx’s Hotspot Panel offers high-sensitivity profiling of critical hotspot regions across 60 oncogenes and tumor suppressor genes, using formalin-fixed, paraffin-embedded (FFPE) tissue samples.
Yes. This test must be ordered by a physician, as the results can impact treatment decisions and require clinical interpretation. Your healthcare provider will determine if the test is appropriate based on your cancer type, stage, and treatment plan.
Bring Precision Oncology to the Bloodstream
Designed for patients with advanced or inoperable tumors, it supports real-time monitoring of disease evolution and treatment resistance.
A Simple Blood Test for Cancer Insights
If you’re living with advanced or inoperable cancer—or your doctor recommended a liquid biopsy—reach out today to learn how this test can support your treatment journey.
*All information is handled with strict confidentiality.